Subtopic Deep Dive
Small Intestinal Ulceration in PHO
Research Guide
What is Small Intestinal Ulceration in PHO?
Small Intestinal Ulceration in PHO refers to chronic nonspecific multiple ulcers of the small intestine linked to SLCO2A1 gene mutations causing primary hypertrophic osteoarthropathy (PHO).
This condition, termed Chronic Enteropathy Associated with SLCO2A1 gene (CEAS), features persistent blood and protein loss from small bowel ulcers distinct from Crohn's disease. Umeno et al. (2015) identified SLCO2A1 mutations via whole-exome sequencing in 9 Japanese families (141 citations). Over 10 papers since 2015 describe endoscopic findings, genetic confirmation, and prostaglandin pathway disruptions.
Why It Matters
Recognizing small intestinal ulceration in PHO expands diagnostic criteria beyond skeletal changes, enabling genetic testing for SLCO2A1 mutations. Umeno et al. (2015) and Umeno et al. (2018) show CEAS patients respond poorly to Crohn's therapies but improve with steroids or surgery, guiding multidisciplinary rheumatology-gastroenterology care (73 citations). Matsuno et al. (2019) validate urinary PGE-MUM measurement as a non-invasive diagnostic tool (26 citations), reducing misdiagnosis rates in Asian cohorts reported by Hong et al. (2022).
Key Research Challenges
Distinguishing from Crohn's Disease
CEAS mimics Crohn's with small bowel ulcers, but lacks granulomas and responds differently to biologics. Umeno et al. (2018) highlight distinct clinical features in 33 patients (73 citations). Yanai et al. (2018) propose SLCO2A1 immunohistochemistry for gastroduodenal biopsies (28 citations).
Non-invasive Genetic Diagnosis
Endoscopy risks and genetic heterogeneity complicate early detection. Matsuno et al. (2019) show elevated PGE-MUM distinguishes CEAS from Crohn's (26 citations). Hong et al. (2022) report similar Korean phenotypes, urging SLCO2A1 sequencing (24 citations).
Limited Therapeutic Options
Steroids provide partial relief, but no targeted therapies exist for prostaglandin dysregulation. Hosoe et al. (2017) characterize 13 CEAS cases unresponsive to anti-TNF (49 citations). Hamon et al. (2022) describe first French cases needing surgery (17 citations).
Essential Papers
A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter
Junji Umeno, Tadakazu Hisamatsu, Motohiro Esaki et al. · 2015 · PLoS Genetics · 141 citations
Previously, we proposed a rare autosomal recessive inherited enteropathy characterized by persistent blood and protein loss from the small intestine as chronic nonspecific multiple ulcers of the sm...
Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn’s disease
Junji Umeno, Motohiro Esaki, Atsushi Hirano et al. · 2018 · Journal of Gastroenterology · 73 citations
The clinical features of CEAS are distinct from those of Crohn's disease. Genetic analysis of the SLCO2A1 gene is therefore recommended in patients clinically suspected of having CEAS.
Chronic Enteropathy Associated With SLCO2A1 Gene [CEAS]—Characterisation of an Enteric Disorder to be Considered in the Differential Diagnosis of Crohn’s Disease
Naoki Hosoe, Naoki Ohmiya, Fumihito Hirai et al. · 2017 · Journal of Crohn s and Colitis · 49 citations
Small intestinal ulcers include mucosal damage caused by drugs, particularly nonsteroidal anti-inflammatory drugs [NSAIDs], infectious diseases, and idiopathic inflammatory bowel disease. Previousl...
A new syndrome of Crohn's disease and pachydermoperiostosis in a family
R. F. COMPTON, W. Sandborn, Huiying Yang et al. · 1997 · Gastroenterology · 30 citations
Distinction between Chronic Enteropathy Associated with the SLCO2A1 Gene and Crohn's Disease
Shunichi Yanai, Satoko Yamaguchi, Shotaro Nakamura et al. · 2018 · Gut and Liver · 28 citations
Immunohistochemical staining for SLCO2A1 in gastroduodenal tissues obtained by endoscopic biopsy is considered useful for the distinction of CEAS from CD.
Immunohistochemical differentiation between chronic enteropathy associated with <i>SLCO2A1</i> gene and other inflammatory bowel diseases
Satoko Yamaguchi, Shunichi Yanai, Shotaro Nakamura et al. · 2018 · Intestinal Research · 27 citations
Immunohistochemical staining of the SLCO2A1 protein is considered useful to distinguish CEAS from other inflammatory bowel diseases.
Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations
Yuichi Matsuno, Junji Umeno, Motohiro Esaki et al. · 2019 · World Journal of Gastroenterology · 26 citations
PGE-MUM measurement is a convenient, non-invasive and useful test for the distinction of CEAS from CD.
Reading Guide
Foundational Papers
Compton et al. (1997, 30 citations) first links Crohn's-like enteropathy to pachydermoperiostosis in a family; read for historical PHO-GI overlap before SLCO2A1 era.
Recent Advances
Hong et al. (2022, 24 citations) on Korean CEAS genetics; Hamon et al. (2022, 17 citations) first French cases for global validation.
Core Methods
Whole-exome sequencing (Umeno et al., 2015), SLCO2A1 immunohistochemistry (Yamaguchi et al., 2018), PGE-MUM assays (Matsuno et al., 2019).
How PapersFlow Helps You Research Small Intestinal Ulceration in PHO
Discover & Search
Research Agent uses searchPapers and exaSearch to find SLCO2A1-related PHO papers like Umeno et al. (2015), then citationGraph reveals 141 citing works and findSimilarPapers clusters CEAS diagnostics.
Analyze & Verify
Analysis Agent applies readPaperContent to extract endoscopy images from Hosoe et al. (2017), verifyResponse with CoVe checks mutation claims against Umeno et al. (2018), and runPythonAnalysis computes PGE-MUM sensitivity (91% per Matsuno et al., 2019) via pandas statistical verification with GRADE B evidence.
Synthesize & Write
Synthesis Agent detects gaps in non-Asian CEAS cohorts via contradiction flagging between Hong et al. (2022) and Hamon et al. (2022); Writing Agent uses latexEditText, latexSyncCitations for SLCO2A1 review manuscripts, and latexCompile with exportMermaid for prostaglandin pathway diagrams.
Use Cases
"Run stats on PGE-MUM levels in CEAS vs Crohn's from Matsuno 2019 and similar papers"
Research Agent → searchPapers('PGE-MUM CEAS') → Analysis Agent → readPaperContent + runPythonAnalysis(pandas t-test on extracted data) → statistical p-values and ROC curves output.
"Draft LaTeX review on SLCO2A1 immunohistochemistry for PHO ulcers"
Synthesis Agent → gap detection → Writing Agent → latexEditText('CEAS diagnostics') + latexSyncCitations(Umeno 2018, Yanai 2018) + latexCompile → camera-ready PDF with figures.
"Find code for SLCO2A1 variant analysis in enteropathy papers"
Research Agent → paperExtractUrls(Umeno 2015) → Code Discovery → paperFindGithubRepo + githubRepoInspect → annotated variant caller scripts for Korean cohort replication.
Automated Workflows
Deep Research workflow scans 50+ SLCO2A1 papers for systematic CEAS review, chaining searchPapers → citationGraph → GRADE grading. DeepScan applies 7-step verification to differentiate CEAS endoscopy from Crohn's via CoVe on Hosoe et al. (2017). Theorizer generates prostaglandin inhibition hypotheses from Matsuno et al. (2019) metabolites.
Frequently Asked Questions
What defines Small Intestinal Ulceration in PHO?
Multiple chronic nonspecific small bowel ulcers due to biallelic SLCO2A1 mutations impairing prostaglandin transport, termed CEAS (Umeno et al., 2015).
What methods distinguish CEAS from Crohn's?
SLCO2A1 gene sequencing, immunohistochemistry on biopsies (Yanai et al., 2018; 28 citations), and urinary PGE-MUM measurement (Matsuno et al., 2019; 26 citations).
What are key papers on this subtopic?
Umeno et al. (2015, 141 citations) discovered SLCO2A1 etiology; Umeno et al. (2018, 73 citations) detailed clinical features in 33 cases; Hosoe et al. (2017, 49 citations) characterized 13 patients.
What open problems remain?
Targeted therapies for prostaglandin excess, validation of PGE-MUM in non-Asian populations, and PHO-CEAS prevalence (Hong et al., 2022; Hamon et al., 2022).
Research Hypertrophic osteoarthropathy and related conditions with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Small Intestinal Ulceration in PHO with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers